FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation - FDA Press Releases

The FDA approved the first antibacterial drug under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD). LPAD was created by Congress to spur development of drugs targeting serious infections in limited patient populations with unmet need.

from Food and Drug Administration--Press Releases https://ift.tt/2OYdQ4r
via IFTTT